Lot-document scope confirmed before quotation · Research use only
  • Specification Review
  • Lot Documents on Request
  • Business Support · Xi’an
  • Destination Eligibility Confirmed
西安诺和达生物科技有限公司

Research & insights

Menotropins Quality Guide: FSH/LH Activity, Source and Units

By NHD Technical TeamPublished Updated Sep 8, 2026

Human menopausal gonadotropin is a biological mixture standardized by FSH and LH activity, not a single compound with one molecular formula.

Evidence at a glance

  • DailyMed describes Menopur as extracted from postmenopausal urine and further purified.
  • Each regulated vial contains 75 IU FSH activity and 75 IU LH activity; hCG is detectable.
  • The label states that FSH and LH activities are measured by separate biological assays standardized to WHO references.
Documentary paired FSH and LH activity-assay workflow
AI-generated editorial illustration illustrating an analytical workflow. It does not depict a supplied product, released lot, approved formulation or assay result.

Identity record

An international unit is defined through biological activity and reference standardization. It is not a direct molecular-weight unit and cannot be reconstructed from total protein mass alone.

MaterialPostmenopausal-urine-derived gonadotropin preparation
Labeled activities75 IU FSH and 75 IU LH activity per Menopur vial
Additional findinghCG detected in Menopur
StandardizationSeparate FSH and LH bioassays linked to WHO international standards
Core QCActivity, identity profile, source, purity, aggregates, contaminants, excipients and lot linkage

Analytical and evidence boundary

Because hMG is a mixture, batch characterization should address component activity and relevant impurities rather than inventing a single sequence or formula. Product-specific purification and excipients also matter.

Regulated product labeling may be cited to explain what a well-defined preparation contains. It must not be presented as the specification for a catalog material unless the actual lot documentation supports equivalence.

Editorial rule

State the exact material, form, model or population and endpoint supported by the cited record. Do not convert mechanistic plausibility, an animal result, an official finished-drug label or an analytical test into a claim about an unrelated catalog lot.

Sources & editorial method

This article discusses the source records listed below, with the study models and limitations stated alongside the findings. AI-assisted drafting and image generation were used. The reference list identifies the records behind this article; it is not an independent peer review or verification of a supplied catalog lot.

3 linked records are listed in the references below. Read the editorial and AI-assistance policy.

How to interpret this article

Source-checked on 2026-09-02. Null results, sample size, model/population limits, finished-drug scope, regulatory status and product-evidence boundaries are retained. This is not medical advice, a customer case or validation of a catalog lot.

Research-use boundary: Catalog materials discussed on this website are for laboratory research, development and manufacturing use only, not for human or veterinary use. This content is not medical advice and does not provide administration instructions.

Primary records and authoritative sources

  1. DailyMed Menopur labelOfficial product description, potency, source and safety context.
  2. Highly purified hMG versus recombinant FSH in high responders620-participant randomized noninferiority trial; PMID 32416978.
  3. HP-hMG versus recombinant FSH in WHO group II infertility184-participant randomized trial; PMID 16571641.
Research pathways

Continue with structured records

Move from this editorial analysis to the product identity, filtered evidence and controlled terminology behind it.

Editorial source check: Site evidence editorial team · 2026-09-02